CIK 0001745648 · <br>Emerging growth company
Apnimed, Inc.
Sign in to watch- Ticker
- APMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821910611
- Phone
- 617-500-8880
- Business address
- 39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +59,303 | 59,303 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −25,574 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +25,574 | 25,574 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −74,128 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +74,128 | 74,128 | ||
| 2026-08-03 | Lind Kevin Robert Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −74,128 | 0 | ||
| 2026-08-03 | Lind Kevin Robert Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +74,128 | 74,128 | ||
| 2026-08-03 | Lind Kevin Robert Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −1,186,278 | 0 | ||
| 2026-08-03 | Lind Kevin Robert Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,186,278 | 1,186,278 | ||
| 2026-08-03 | Lind Kevin Robert Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −108,916 | 0 | ||
| 2026-08-03 | Lind Kevin Robert Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +108,916 | 108,916 | ||
| 2026-08-03 | Sender Gary Director | Returned to the company · Stock Option (Right to Buy) | −51,890 | 0 | ||
| 2026-08-03 | Sender Gary Director | Grant or award · Stock Option (Right to Buy) | +51,890 | 51,890 | ||
| 2026-08-03 | Sender Gary Director | Returned to the company · Stock Option (Right to Buy) | −44,477 | 0 | ||
| 2026-08-03 | Sender Gary Director | Grant or award · Stock Option (Right to Buy) | +44,477 | 44,477 | ||
| 2026-08-03 | Sender Gary Director | Returned to the company · Stock Option (Right to Buy) | −44,477 | 0 | ||
| 2026-08-03 | Sender Gary Director | Grant or award · Stock Option (Right to Buy) | +44,477 | 44,477 | ||
| 2026-08-03 | JONES WILLIAM A JR Director | Returned to the company · Stock Option (Right to Buy) | +44,477 | 0 | ||
| 2026-08-03 | JONES WILLIAM A JR Director | Grant or award · Stock Option (Right to Buy) | +44,477 | 44,477 | ||
| 2026-08-03 | Molnar Dennis Patrick President | Returned to the company | −58,014 | 0 |
Page 4 of 6 · 104 trades